News

Collaboration aims to expedite the transportation of cancer detection radiopharmaceuticals throughout Chile.

Financial commitment is intended to benefit development and commercialization of new products.

Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.

Organization hires Kala Shankle, who joins the team with supply chain security and drug pricing experience.

IATA statistics suggest improvement over recent months.

Novo Nordisk receives the full rights to develop and commercialize the lead program.

Pharma Commerce provides a synopsis of the presentation.

Biopharma company now required to seek approval before attempting further buyouts.

Shift comes with $5 million dedication to launch Cencora’s healthier futures grant program.

Delay to allow agency to consider other ways of solving the issue, filing says.

The latest people news happenings over the past month.

Collaboration to focus on digital therapeutics.

After concerns raised by multiple supply chain participants over readiness, the agency steps back.

Program designed to aid life science organizations in improving go-to-market strategy.

Expansion allows facility to provide E2E services in one location, including commercial manufacturing.

The deal helps the logistics provider—who operates in the healthcare space—continue to grow its services.

Program’s goal is to maximize aviation industry’s contribution to development across the African continent.

Abrysvo is allowed to be given to individuals who are 32-36 weeks pregnant.

Acquisition expands 3PL’s presence in India, adds 7.7 million square feet of facility space.

Delays could harm older Americans, interest group states.

In what could presage a radical reshuffling of drug pricing and distribution, the insurer is dropping CVS Caremark as its PBM.

Guidelines expected to assist companies with EPCIS-based sTI/TS data exchange as they prepare to meet November DSCSA deadlines.

The act is currently set to go into effect in just over three months.

H1 Mobile to offer latest information and research in multiple fields.

Analysis requested by PhRMA indicates that these facilities charge anywhere from two to seven times what they originally paid.

The company anticipates that the offering will help maximize life sciences brands’ commercial potential.

Experienced pharma exec joins the business’ management board.